Walgreens Boots Alliance, Inc. (WBA)
NASDAQ: WBA · Real-Time Price · USD
11.05
-0.13 (-1.16%)
Apr 3, 2025, 10:33 AM EDT - Market open
Walgreens Boots Alliance Revenue
Walgreens Boots Alliance had revenue of $39.46B in the quarter ending November 30, 2024, with 7.50% growth. This brings the company's revenue in the last twelve months to $150.41B, up 5.62% year-over-year. In the fiscal year ending August 31, 2024, Walgreens Boots Alliance had annual revenue of $147.66B with 6.17% growth.
Revenue (ttm)
$150.41B
Revenue Growth
+5.62%
P/S Ratio
0.06
Revenue / Employee
$454,411
Employees
331,000
Market Cap
9.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 147.66B | 8.58B | 6.17% |
| Aug 31, 2023 | 139.08B | 6.38B | 4.81% |
| Aug 31, 2022 | 132.70B | 194.00M | 0.15% |
| Aug 31, 2021 | 132.51B | 10.53B | 8.63% |
| Aug 31, 2020 | 121.98B | 1.91B | 1.59% |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
WBA News
- 1 day ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields - Benzinga
- 6 days ago - Walgreens Settles Allegations of Submitting Inflated Prices to Medicaid Programs - PYMNTS
- 6 days ago - Walgreens to pay more than $2.85 million to settle US overbilling charges - Reuters
- 6 days ago - Walgreens Agrees to Pay About $2.8 Million to Resolve Medicaid-Overbilling Allegations - Market Watch
- 16 days ago - Walgreens Boots' Stefano Pessina to almost double stake after Sycamore takeover, FT reports - Reuters
- 20 days ago - The drugstore industry is struggling. Here's what could be in its future. - Market Watch
- 22 days ago - Stocks beating the stock market's recent Trump slump have this in common - Market Watch
- 26 days ago - Walgreens Boots Alliance: A Great Risk To Reward Opportunity With This $23.7 Billion Buyout - Seeking Alpha